It regulates the expression of genes associated with metabolic pathways, such as aldo-keto reductase family 1 member B1 (AKR1B1), which mediates the cytotoxicity of 2-deoxyglucose, thereby promoting the progression of glioma [40]. The gene discussed is AKR1B1; the disease is central nervous system cancer.